A043090 Stock Overview
The Technology Co.,Ltd. manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
The Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩437.00 |
| 52 Week High | ₩2,545.00 |
| 52 Week Low | ₩386.00 |
| Beta | 0.12 |
| 1 Month Change | -14.31% |
| 3 Month Change | 2.82% |
| 1 Year Change | -81.87% |
| 3 Year Change | -78.15% |
| 5 Year Change | -88.19% |
| Change since IPO | -94.23% |
Recent News & Updates
Shareholder Returns
| A043090 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -2.9% | -0.8% | 2.7% |
| 1Y | -81.9% | 3.6% | 5.8% |
Return vs Industry: A043090 underperformed the KR Life Sciences industry which returned 3.6% over the past year.
Return vs Market: A043090 underperformed the KR Market which returned 5.8% over the past year.
Price Volatility
| A043090 volatility | |
|---|---|
| A043090 Average Weekly Movement | 12.3% |
| Life Sciences Industry Average Movement | 7.5% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A043090 has not had significant price volatility in the past 3 months.
Volatility Over Time: A043090's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 21 | Young-Jin Kwon | www.pharmswell.com |
The Technology Co.,Ltd. manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea. It primarily provides active pharmaceutical ingredients.
The Technology Co.,Ltd. Fundamentals Summary
| A043090 fundamental statistics | |
|---|---|
| Market cap | ₩30.85b |
| Earnings (TTM) | -₩27.11b |
| Revenue (TTM) | ₩15.89b |
1.9x
P/S Ratio-1.1x
P/E RatioIs A043090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A043090 income statement (TTM) | |
|---|---|
| Revenue | ₩15.89b |
| Cost of Revenue | ₩14.28b |
| Gross Profit | ₩1.62b |
| Other Expenses | ₩28.73b |
| Earnings | -₩27.11b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -384.01 |
| Gross Margin | 10.18% |
| Net Profit Margin | -170.57% |
| Debt/Equity Ratio | 23.4% |
How did A043090 perform over the long term?
See historical performance and comparison